A future in-depth gene expression analysis in CDKL5 and MeCP2-null conditions could be crucial in order to clarify the similarities and differences between CDD and RTT in terms of their cardiac phenotypes. The gene discussed is MECP2; the disease is craniodiaphyseal dysplasia.